Beware of surrogate outcome measures

Area of Science:

• Clinical research methodology
• Biostatistics
• Evidence-based medicine

Background:

• Surrogate outcome measures offer potential for faster clinical research by enabling earlier assessment compared to primary outcomes.
• The use of surrogate endpoints is a common strategy in clinical trials to expedite the evaluation of new interventions.

Purpose of the Study:

• To review the justification for using surrogate outcome measures in clinical research.
• To evaluate the potential risks and benefits associated with reliance on surrogate endpoints.
• To provide recommendations on the interpretation and application of results derived from surrogate outcome measures.

Main Methods:

• Literature review of studies utilizing surrogate outcome measures.
• Analysis of the theoretical basis and empirical evidence supporting the use of surrogate endpoints.
• Critical evaluation of the validity and reliability of surrogate outcome measures in predicting clinical benefit.

Main Results:

• While surrogate outcomes can accelerate research timelines, their use may introduce significant risks.
• Reliance on surrogate measures can lead to premature conclusions about treatment efficacy.
• Evidence suggests that surrogate outcomes may not always accurately reflect true clinical benefit.

Conclusions:

• Results obtained using surrogate outcome measures should be treated as preliminary and require cautious interpretation.
• Extensive, definitive clinical trials focusing on clinically relevant outcomes are essential before widespread adoption of new interventions.
• Over-reliance on surrogate endpoints may be harmful to patient care and scientific integrity.